维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="SAFFROY R"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Prospective evaluation of blood concentration of mitochondral DNA as a marker of toxicityin 157consecutively recruited untreated or HAART-treated HIV-positive patients显示文摘	Chiappini F Teicher E Saffroy R		0，，07：	1
2	New perspectives and strategy research biomarkers for hepatocellular carcinoma显示文摘	Saffroy R Pham P Reffas M	2007	Clin Chem Lab Med2007，45，：	1
3	New perspectives and strategy research biomarkers for hepatocellular carcinoma 显示文摘	Saffroy R Pham P Reffas M	2007	Clin Chem Lab Med2007，45，9：	1
4	Microsatellite instability in European hepatocellular carcinoma显示文摘	Salvucci M Lemoine A Saffroy R	1999	Oncogene1999，18，1：	1
5	New perspectives and strategy research biomarkers for hepatocellular carcinoma显示文摘	Saffroy R Pham P Reffs M	2007	Clin Chem Lab Med2007，45，9：	1
6	Protective effect against alcohol dependence of the thermolabile variant of MTHFR显示文摘	Saffroy R Benyamina A Pham P	2008	Drug Alcohol Depend2008，96，12：	1
7	Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis显示文摘	Bachelot-Loza C Saffroy R Lasne D	1998	Thromb Haemost1998，79，：	1
8	New perspectives and strategy research biomarkers for hepatocellular carcinoma 显示文摘	Saffroy R Pham P Reffas M	2007	Clin Chem Lab Med2007，45，9：	1
9	Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma显示文摘	Riou P Saffroy R Chenailler C	2006	FASEB J2006，20，13：	1
10	Realtime quantification of AFP mRNA to assess hematogenous dissemination after transarterial ehemoembolization of hepatocellular carcinoma 显示文摘	GROSS-GOUPIL M SAFFROY R AZOULAY D	2003	Ann Surg2003，238，2：	1
11	Real-time quartitation of bcr-abl trarlscripts in haeematological malignancies显示文摘	Saffroy R Lemoine A Brezillon P	2000	Euro J Haematol2000，65，4：	1
12	New perspectives and strategy research biomarkers for hepatocellular carcinoma 显示文摘	Saffroy R Pham P Reffas M	2007	Clin Chem Lab Med2007，45，9：	1
13	New perspectives and strategy research biomarkers for hepatocellular carcinoma显示文摘	Saffroy R Pham P Reffas M	2007	Clin Chem Lab Med2007，45，9：	1
14	Analysis of alterations of WFDC-I, a new pu- tative tumor suppressor gene , in hepatocellular carcinoma 显示文摘	Saffroy R Riou P Soler G ct al	2002	European Jour- nal of Human Genetles2002，10，4：	1
15	Clinical significanceof circulating anti-p53 antibodies in European patients withhepatocellular carcinoma显示文摘	Saffroy R Lelong JC Azoulay D	1999	Br J Cancer1999，79，34：	1
16	Expression of T-cadherin in tumor cells influences invasive potential of human hepatovellular carcinoma显示文摘	Riou P Saffroy R Chenailter C	2006	FASEB J2006，20，13：	1
17	Clinical significance of circulating anti -P53 antibodies in European patients with hepatocellular carcinoma显示文摘	Saffroy R Lelong JC Azoulay D	1999	Br J Cancer1999，79，34：	1
18	Environmental risk factors in primary liver eancer: a review of the literature and perspeetives for primary prevention and early detection 显示文摘	DEGLI ESPOSTI D PHAM P SAFFROY R	2014	Eur J Oncol2014，14，3：	1
19	Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma显示文摘	Gross-Goupil M Saffroy R Azoulay D etal	2003	Ann Surg2003，238，2：	1
20	New perspectives and strategy research biomarkers for hepatocellular carcinoma显示文摘	Saffroy R Pham P Reffas M	2007	Clin Chem Lab Med2007，45，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示